Literature DB >> 24242082

Long-term results of probing guided with soft cannula in children with congenital nasolacrimal duct obstruction.

Dilek Yuksel1, Pınar Altiaylik Ozer.   

Abstract

PURPOSE: To report the results of soft probing in children with congenital nasolacrimal duct obstruction (CNLDO).
MATERIALS AND METHODS: A prospective, non-randomised interventional study included 158 eyes of 122 children aged 2 months-5 years, with CNLDO. A plastic intravenous catheter sheath supported intraluminally with a guiding metal probe was introduced through the superior canaliculus. During intubation, the plastic cannula was gently introduced through the nasolacrimal system, while the metal probe inside was withdrawn concurrently. After the complete withdrawal of the metal probe, the duct was irrigated with a high pressure saline solution through the plastic cannula. Once the obstruction was totally dissolved and a patent passage was observed, the plastic cannula was withdrawn and the procedure was completed with a nasolacrimal lavage with a gentamycin and dexamethasone combination.
RESULTS: Clinically successful results were achieved in 142 eyes (89.8 %). No significant complications occured intraoperatively or postoperatively.
CONCLUSIONS: In children under age 5, our technique has a high success rate with no significant complications. This method allows probing in a more controlled way. This method may be particularly suitable for surgeons during training, when the most false lumen formation is observed.

Entities:  

Mesh:

Year:  2013        PMID: 24242082     DOI: 10.1007/s10384-013-0289-x

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  22 in total

1.  Epiphora during the first year of life.

Authors:  C J MacEwen; J D Young
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

2.  Balloon dilatation for treatment of congenital nasolacrimal duct obstruction.

Authors:  D Yüksel; K Ceylan; O Erden; R Kiliç; S Duman
Journal:  Eur J Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 2.597

3.  Congenital nasolacrimal duct obstruction in the second year of life: a multicentre trial of management.

Authors:  J D Young; C J MacEwen; S A Ogston
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

4.  Long-term results after probing for congenital nasolacrimal duct obstruction.

Authors:  S M Sturrock; C J MacEwen; J D Young
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

5.  Comparison of two endoscopically assisted procedures in primary surgical treatment of congenital nasolacrimal duct obstruction in children older than 3 years: balloon dilatation and bicanalicular silicone tube intubation.

Authors:  K Ceylan; D Yuksel; S Duman; E Samim
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-09-22       Impact factor: 1.675

6.  Stepwise treatment paradigm for congenital nasolacrimal duct obstruction.

Authors:  Douglas R Casady; Dale R Meyer; John W Simon; George O Stasior; Jitka L Zobal-Ratner
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Jul-Aug       Impact factor: 1.746

7.  Outcome of probing for congenital nasolacrimal duct obstruction in older children.

Authors:  S G Honavar; V E Prakash; G N Rao
Journal:  Am J Ophthalmol       Date:  2000-07       Impact factor: 5.258

8.  The results of late probing in congenital nasolacrimal duct obstruction.

Authors:  Güler Zilelioğlu; Banu M Hoşal
Journal:  Orbit       Date:  2007-03

9.  Success rates of nasolacrimal duct probing at time intervals after 1 year of age.

Authors:  R M Robb
Journal:  Ophthalmology       Date:  1998-07       Impact factor: 12.079

10.  Treatment of congenital nasolacrimal system obstruction.

Authors:  J D Baker
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1985 Jan-Feb       Impact factor: 1.402

View more
  1 in total

Review 1.  Insights in the treatment of congenital nasolacrimal duct obstruction.

Authors:  Elena Avram
Journal:  Rom J Ophthalmol       Date:  2017 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.